The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6733182 7351170 F 6733182-7 20100301 20100514 20100520 PER US-BIOGENIDEC-2010BI011238 BIOGEN IDEC INC. 55 YR F Y 20100520 OT UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6733182 1013718664 PS TYSABRI 1 INTRAVENOUS

Indications of drugs used

Event ID DRUG SEQ INDI PT
6733182 1013718664 MULTIPLE SCLEROSIS

Outcome of event

Event ID OUTC COD
6733182 HO

Reactions reported

Event ID PT
6733182 APHASIA
6733182 COMMUNICATION DISORDER
6733182 CONFUSIONAL STATE
6733182 DEPRESSION
6733182 DISORIENTATION
6733182 MULTIPLE SCLEROSIS RELAPSE
6733182 SPEECH DISORDER

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6733182 1013718664 20100304